Found: 1
Select item for more details and to access through your institution.
Cost‐effectiveness analysis of osimertinib plus chemotherapy for patients with EGFR‐mutated advanced non‐small cell lung cancer.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 16, p. 1, doi. 10.1002/cam4.70083
- By:
- Publication type:
- Article